(E)-6-Iodo-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, 98%, 10g

[(3,4-dimethoxyphenyl)methyl](propyl)amine, 95.0%, 1g

tert-Butyl 7-(aminomethyl)-5-oxa-2-azaspiro[3.4]octane-2-carboxylate, 97%, 100mg

(2,2-dimethyl-1,3-dioxan-5-yl)amine, 95.0%, 250mg

(3-Methylisoxazol-5-yl)methanol, 95.0%, 250mg

N-benzyltetrahydro-3-thiophenamine 1,1-dioxide hydrochloride, 95.0%, 10g

Methyl indole-4-carboxylate, 98.0%, 10g

Methyl 3-Amino-2-methylbenzoate>98.0%(GC)(T)25g

Methyl 2-bromo-2-(4-fluorophenyl)acetate, 95.0%, 1g

(4S,4'S)-2,2'-(1,3-Di(quinolin-2-yl)propane-2,2-diyl)bis(4-benzyl-4,5-dihydrooxazole), 97%, 250mg

(4-Aminosulfonylphenyl)boronic acid, 95.0%, 10g

N4-((3aS,4R,6S,6aR)-6-(2-((tert-butyldimethylsilyl)oxy)ethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)-6-chloro-2-(propylthio)pyrimidine-4,5-diamine, 95%, 100mg

Hexachloroplatinic (IV) acid hexahydrate, 40% Pt, 1 g, glass packaging